Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy.

By Matthew C. Hull, Christopher G. Morris, Carl J. Pepine, N. Mendenhall. Journal of the American Medical Association (JAMA), 2003

634 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Neurology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/2ead828b66b5859c47851993235ab4a0c5e42ea4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Pathology and Forensic Medicine

Jeroen J. Bax

Citations in the corpus

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016, background): “The risk of myocardial infarction in patients treated for Hodgkin lymphoma is two- to seven-fold higher than in the general population, with a cumulative incidence of 10% at 30 years.(7,81,99)”
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016, background): “The risk of myocardial infarction in patients treated for Hodgkin lymphoma is two- to seven-fold higher than in the general population, with a cumulative incidence of 10% at 30 years.(7,81,99)”
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations (2020, background): “Radiation-induced valvular disease is an increasingly recognised entity occurring late after mediastinal RT with a median time to diagnosis of 22 years.(31) RT induces thickening, fibrosis, retraction and calcification of valvular tissue that continues for at least 20 years, regardless of patient ag”
Epidemiology of valvular heart disease in the adult (2011, neutral): “Other emerging rare etiologies include radiation-induce”
A population-based study of cardiovascular disease mortality risk in US cancer patients. (2019, background): “Previous studies reported CVDs in malignancies of breast,(22,23) head and neck,(24) prostate,(24) testicular,(25) renal cell carcinoma,(26) endometrium,(27) and Hodgkin lymphoma.(28) A previous report by AbdelRahman assessed heart disease-specific mortality for 10 cancer sites in cancer survivors wh”